Current Problems in Pediatric and Adolescent Health Care
Volume 37, Issue 6 , Pages 207-246 , July 2007

Headaches in Children and Adolescents

References 

  1. Bille B. Migraine in school children. Acta Paediatr. 1962;51(Suppl):1–151136
  2. Deubner DC. An epidemiologic study of migraine and headache in 10-20 year olds. Headache. 1977;17:173–180
  3. Sillanpaa M. Changes in the prevalence of migraine and other headache during the first seven school years. Headache. 1983;23:15–19
  4. Dalsgaard-Nielsen T. Some aspects of the epidemiology of migraine in Denmark. Headache. 1970;10:14–23
  5. Laurell K, Larsson B, Eeg-Olofsson O. Prevalence of headache in Swedish schoolchildren, with a focus on tension-type headache. Cephalalgia. 2004;24:380–388
  6. Rothner AD. The evaluation of headaches in children and adolescents. Semin Pediatr Neurol. 1995;2:109–118
  7. The Childhood Brain Tumor Consortium. The epidemiology of headache among children with brain tumors. J Neurooncol. 1991;10:31–46
  8. Lewis DW, Ashwal S, Dahl G, Dorbad D, Hirtz D, Prensky A, et al. Practice parameter: evaluation of children and adolescents with recurrent headache. Neurology. 2002;59:490–498
  9. Dalsgaard-Nielsen T. Some aspects of the epidemiology of migraine in Denmark. Headache. 1970;10:14–23
  10. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319–328
  11. Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, Vahlquist and IHS criteria. Dev Med Child Neurol. 1992;34:1095–1101
  12. Valquist B. Migraine in children. Int Arch Allergy. 1955;7:348–355
  13. Small P, Waters WE. Headache and migraine in a comprehensive school. In:  Waters WE editors. The Epidemiology of Migraine. Bracknell-Berkshire, England: Boehringer Ingel-helm, Ltd; 1974;p. 56–67
  14. Sillanpaa M. Prevalence of migraine and other headache in Finnish children starting school. Headache. 1976;15:288–290
  15. Stewart WF, Liner MS, Celentano DD, Van Natta M, Siegler D. Age and sex-specific incidence rates of migraine with and without visual aura. Am J Epidemiol. 1991;34:1111–1120
  16. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. JAMA. 1992;267:64–69
  17. Valquist B. Migraine in children. Internat Arch Allergy. 1955;7:348–355
  18. Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506–510
  19. Oleson J. The international classification of headache disorders. Cephalalgia. 2004;24(Suppl 1):1–160
  20. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev. 2003;4:386–398
  21. Ward TN, Levin M. Diagnosis and pathophysiology of migraine. Exp Rev Neurother. 2004;4:383–390
  22. Silberstein S. Migraine. Lancet. 2004;31:381–391
  23. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol. 2000;47:614–624
  24. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with Triptans: a race against the development of cutaneous allodynia. Ann Neurol. 2004;55:19–26
  25. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol. 2004;55:27–36
  26. Hachinshi VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology. 1973;23:570–579
  27. Bickerstaff ER. Basilar artery migraine. Lancet. 1961;1:15–17
  28. Lapkin ML, Golden GS. Basilar artery migraine, a review of 30 cases. Am J Dis Child. 1978;132:278–281
  29. Golden GS, French JH. Basilar artery migraine in young children. Pediatrics. 1975;56:722–726
  30. La Spina I, Vignati A, Porazzi D. Basilar artery migraine: transcranial Doppler EEG and SPECT from the aura phase to the end. Headache. 1997;37:43–47
  31. Joutel A, Bousser M-G, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40–45
  32. Gardner K, Barmada MM, Ptacek LJ, et al. A new locus for hemiplegic migraine maps to chromosome 1q31. Neurology. 1997;49:1231–1238
  33. Barlow CF. Headaches and migraine in childhood. Clin Dev Med. 1984;91:93–103
  34. Symon DN. Is there a place for “abdominal migraine” as a separate entity in the I.H.S. classification? (Yes!). Cephalalgia. 1992;12:345–346
  35. Mortimer MJ, Kay J, Jaron A. Clinical epidemiology of childhood abdominal migraine in an urban general practice. Dev Med Child Neurol. 1993;35:243–248
  36. Dignan F, Abu-Arafeh I, Russell G. The prognosis of abdominal migraine. Arch Dis Child. 2001;84:415–418
  37. Bentley D, Kehley A, AlBayaty M, Michie C. Abdominal migraine as a cause of vomiting in children: a clinician’s view. J Pediatr Gastroenterol Nutr. 1995;21(Suppl 1):S49–S51
  38. Russell G, Abu-Arafeh I, Symon DN. Abdominal migraine—evidence for existence and treatment options. Pediatr Drugs. 2002;4:1–8
  39. Dignan F, Abu-Arafeh I, Russell G. The prognosis of childhood abdominal migraine. Arch Dis Child. 2001;84:415–418
  40. Chaves-Carballo E. Paroxysmal torticollis. Semin Pediatr Neurol. 1996;3:255–256
  41. Chutorian AM. Benign paroxysmal torticollis, tortipelvis and retrocollis of infancy. Neurology. 1974;24:366–367
  42. Snyder CH. Paroxysmal torticollis in infancy (A possible form of labyrinthitis). Am J Dis Child. 1969;117:458–460
  43. Griffin N, Benton S, Goadsby P. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol. 2002;44:490–493
  44. Swoboda K, Danavalkis E, Xaidara A, et al. Alternating hemiplegia of childhood or familial hemiplegic migraine? (A novel ATP1A2 mutation). Ann Neurol. 2004;55:884–887
  45. Verret S, Steele JC. Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy. Pediatrics. 1971;47:675–680
  46. Aicardi J, Bourgeois M, Goutieres F. Alternating hemiplegia of childhood: clinical findings and diagnostic criteria. In:  Andermann F,  Aicardi J,  Vigevano F editor. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995;p. 3–18
  47. Rho JM, Chugani HT. Alternating hemiplegia of childhood: insights into its pathogenesis. J Child Neurol. 1998;13:39–45
  48. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache. (an evidence-based review) Neurology. 2000;55:754–762
  49. Powers S, Patton S, Hommel K, Hershey A. Quality of life in childhood migraine: clinical aspects and comparison to other chronic illness. Pediatrics. 2003;112:e1–e5
  50. Powers S, Patton S, Hommell K, Hershey A. Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0. Cephalalgia. 2004;24:120–127
  51. Holroyd K, Mauskop A. Complementary and alternative treatments. Neurology. 2003;60(Suppl 2):58–62
  52. Miller V, Palermao T, Powers S, et al. Migraine headaches and sleep distrurbances in children. Headache. 2003;43:362–368
  53. Koseoglu E, Akboyraz A, Soyuer A, Ersoy AO. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia. 2003;23(10):972–976
  54. Millichap J, Yee M. The diet factor in pediatric and adolescent migraine. Pediatric Neurol. 2003;28:9–15
  55. Stang P, Yanagihar P, Swanson J, et al. Incidence of migraine headache: a population based study in Olmsted Country, Minn. Neurology. 1992;42:1657–1662
  56. Van den Bergh V, Amery W, Waelkens J. Trigger factors in migraine: a study conducted by the Belgian Migraine Society. Headache. 1987;27:191–196
  57. Gibb C, Davies P, Glover V, et al. Chocolate is a migraine-provoking agent. Cephalalgia. 1991;11:93–95
  58. Lewis DW, Middlebrook MT, Mehallick L, Rouch TM. Pediatric headaches: what do the children want?. Headache. 1996;36:224–230
  59. James JE. Acute and chronic effects of caffeine on performance, mood, headache, and sleep. Neuropsychobiology. 1998;38:32–41
  60. Mannix LK, Frame JR, Soloman GD. Alcohol, smoking and caffeine use among headache patients. Headache. 1997;37:572–576
  61. Dusseldorp M, Katan M. Headache caused by caffeine withdrawal among moderate caffe drinkers switched from ordinary to decaffeinated coffee: a 12 week double-blind trial. BMJ. 1990;300:1558–1559
  62. Reimschisel T. Breaking the cycle of medication overuse headache. Contemp Pediatr. 2003;20:101
  63. Rothner A, Guo Y. An analysis of headache types, over-the-counter (OTC) medication overuse and school absences in a pediatric/adolescent headache clinic. Headache. 2004;44:490
  64. Baumann RJ. Behavioral treatment of migraine in children and adolescents. Paediatr Drugs. 2002;4(9):555–561
  65. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593–597
  66. Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215–2224
  67. Hamalainen ML, Hoppu K, Valkeila E, et al. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology. 1997;48:102–107
  68. Lewis D, Kellstein D, Burke B, et al. Children’s ibuprofen suspension for the acute treatment of migraine headache. Headache. 2002;42:780–786
  69. Winner P, Pensky A, Linder S. Efficacy and safety of oral sumatriptan in adolescent migraines. 1996;Presented at the American Association for the Study of Headache scientific meeting, Chicago, IL, May
  70. Ueberall MA. Intranasal sumatriptan for the acute treatment of migraine in children. Neurology. 1999;52:1507–1510
  71. Winner P, Rothner AD, Saper J, et al. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics. 2000;106:989–997
  72. Ahonen K, Hamalainen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology. 2004;62:883–887
  73. Linder SL. Subcutaneous sumatriptan in the clinical setting (The first 50 consecutivepatients with acute migraine in a pediatric neurology office practice). Headache. 1996;36:419–422
  74. Winner P, Lewis D, Visser WH, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind placebo-controlled study. Headache. 2002;42:49–55
  75. Linder SL, Dowson AJ. Zolmitriptan provides effective migraine relief in adolescents. Int J Clin Prac. 2000;54:466–469
  76. Winner P, Lewis D, Hershey A, et al. Unique study design demonstrates that zolmitriptan 5 mg nasal spray is effective and well tolerated in the acute treatment of adolescent migraine (Headache 2005: Late breaking platform presentation at the June American Headache Society meeting in Philadelphia). 2005;June
  77. Lewis D, Diamond S, Scott D. Prophylactic treatment of pediatric migraine. Headache. 2004;44:230–237
  78. Hershey AD, Powers SW, Bentti AL, deGrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000;40:539–549
  79. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001;41:968–975
  80. Hershey AD, Powers SW, Vockell AL, et al. Effectiveness of topiramate in the prevention of childhood headache. Headache. 2002;42:810–818
  81. Winner P, Pearlman E, Linder S, et al. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45:1304–1312
  82. Caruso JM, Brown WD, Exil G, Gascon GG. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache. 2000;40:672–676
  83. Serdaroglu G, Erhan E, Tekgul , et al. Sodium valproate prophylaxis in childhood migraine. Headache. 2002;42:819–822
  84. Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004;44:238–243
  85. Belman AL, Milazo M, Savatic M. Gabapentin for migraine prophylaxis in children. Ann Neurol. 2001;50(Suppl 1):S109
  86. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol. 1974;50:109–115
  87. Forsythe WI, Gillies D, Sills MA. Propranolol (Inderal) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26:737–741
  88. Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593–597
  89. Noronha MJ. Double-blind randomized cross-over trial of timolol in migraine prophylaxis in children. Cephalalgia. 1985;5(Suppl 3):174–175
  90. Battistella PA, Ruffilli R, Moro R, Fabiani M, Bertoli S, Antolini A, et al. A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache. 1990;30:264–268
  91. Sorge F, Marano E. Flunarizine v. placebo in childhood migraine (A double-blind study). Cephalalgia. 1985;5(Suppl 2):145–148
  92. Sorge F, DeSimone R, Marano E, et al. Flunarizine in prophylaxis of childhood migraine (A double-blind, placebo-controlled crossover study). Cephalalgia. 1988;8:1–6
  93. Guidetti V, Moscato D, Ottaviano S, et al. Flunarizine and migraine in childhood an evaluation of endocrine function. Cephalalgia. 1987;7:263–266
  94. Lewis DW, Middlebrook MT, Deline C. Naproxen sodium for chemoprophylaxis of adolescent migraine. Ann Neurol. 1994;36:542
  95. Victor S, Ryan S. Drugs for preventing migraine headaches in children. Cochrane Database System Reviews. 2003;4:CD 002761
  96. Norton J. Use of intravenous valproate sodium in status migraine. Headache. 2000;40:755–757
  97. Linder S. Treatment of childhood headache with dihydroergotamine mesylate. Headache. 1994;34:578–580
  98. Ayatollahi SMT, Moradi F, Ayatollahi SAR. Prevalence of migraine and tension-type headache in adolescent girls of Shiraz (Southern Iran). Headache. 2002;42:287–290
  99. Deleu D, Mushtaq K, Tariq A. Prevalence and clinical characteristics of headache in a rural community in Oman. Headache. 2002;42:963–971
  100. Gladstein J, Holden W. Chronic daily headache in children and adolescents: a 2-year prospective study. Headache. 1996;36:349–351
  101. Barea L, Tannhauser M, Rotta N. An epidemiological study of headache among children and adolescents in southern Brazil. Cephalalgia. 1996;16:545–549
  102. Zwart J, Dyb G, Holmen T, et al. The prevalence of migraine and tension-type headache among adolescents in Norway. Cephalalgia. 2004;24:373–379
  103. Gallai V, Sarchielli P, Carboni F, Benedetti P, Mastropaolo C, Puca F Juvenile Headache Collaborative Study Group. Applicability of the 1988 IHS criteria to headache patients under the age of 18 years attending 21 Italian headache clinics. Headache. 1995;35:146–153
  104. Wober-Bingol C, Wober C, Wagner-Ennsgraber C, et al. I.H.S. for migraine and tension-type headache in children and adolescents. Headache. 1996;36:231–238
  105. Aromaa M, Sillanpaa M, Rautava P, Helenius H. Childhood headache at school entry. Neurology. 1998;50:1729–1736
  106. Anttila P, Sourander A, Metsahonkala L, et al. Psychiatric symptoms in children with primary headache. J Am Acad Child Adol Psychiatry. 2004;43:412–419
  107. Bille B. Migraine in childhood and it’s prognosis. Cephalagia. 1981;1:71–75
  108. Grazzi L, Andrasik F, Usai S, et al. Pharmacological behavioral treatment for children and adolescents with tension-type headache. Neurol Sci. 2004;70–271
  109. Larsson B, Melin L, Doderl A. Recurrent tension headache in adolescent treated with self-help relaxation training and a muscle relaxant drug. Headache. 1990;30:665–671
  110. Fichtel A, Larsson B. Does relaxation treatment have differential effects on migraine and tension-type headache in adolescents?. Headache. 2001;41:290–296
  111. Fichtel A, Larsson B. Relaxation treatment administered by school nurses to adolescents with recurrent headache. Headache. 2004;44:545–554
  112. Andrasik F, Grazzi L, Usai S, et al. Brief neurologist-administered behavioral treatment of pediatric episodic tension-type headache. Neurology. 2003;60:1215–1216
  113. Amdorfer R, Allen K. Extending the efficacy of a thermal biofeedback treatment package to the management of tension-type headache in children. Headache. 2001;41:183–192
  114. Bussone G, Grazzi L, D’Amical D, et al. Biofeedback assisted relaxation training for young adolescents with tension-type headache. Cephalalgia. 1998;18:463–467
  115. Anttila P, Sourander A, Metsahonkala L, Aromaa M, Helenius H, Sillanpaa M. Psychiatric symptoms in children with primary headache. J Am Acad Child Adolesc Psychiatry. 2004;43:412–419
  116. Fearon P, Hotopf M. Relation between headache in childhood and physical and psychiatric symptoms in adulthood national birth cohort study. Br Med J. 2001;322:1145–1148
  117. Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ. 1994;309:765–769
  118. Lipton R, Stewart W. Prevalence and impact of migraine. Neurol Clin. 1997;15:1–13
  119. Castillo J, Munoz P, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache. 1999;39:190–196
  120. Viswanathan V, Bridges SJ, Whitehouse W, Newton RW. Childhood headaches: discrete entities or continuum?. Dev Med Child Neurol. 1998;40:544–550
  121. Mathew NT, Kurman R, Perez F. Drug-induced refractory headache—clinical features and management. Headache. 1990;30:634–638
  122. Lampl C. Childhood-onset cluster headache. Pediatr Neurol. 2002;27:138–140
  123. Ekbom K, Ahlborn B, Schele R. Prevalence of migraine and cluster headache in Swedish men of 18. Headache. 1978;18:9–19
  124. Maytal J, Lipton R, Solomon S, Shinnar S. Childhood onset cluster headache. Headache. 1992;32:275–279
  125. Freitag F. Cluster headache. Prim Care. 2004;31:313–329
  126. Dodick D, Saper J. Cluster and chronic daily headache. Neurology. 2003;60:S31–S37
  127. Lewis D, Avner M, Gozzo Y. The “other” primary headaches in children and adolescents. Pediatr Neurol. 2005;(in press)
  128. Benoliel R, Sharav Y. Paroxysmal hemicrania. Oral Surg Oral Med Oral Pathol. 1998;85:285–292
  129. Goadsby P, Lipton R. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. 1997;120:193–209
  130. Shabbir N, McAbee G. Adolescent chronic paroxysmal hemicrania responsive to verapamil monotherapy. Headache. 1994;34:209–210
  131. Gladstein J, Holden W, Peralta L. Chronic paroxysmal hemicrania in a child. Headache. 1994;34:519–520
  132. Sjaastad O, Russell D, Horven I, Bunnaes U. Multiple neuralgiform unilateral headache attacks associated with conjuctival injection and appearing in clusters: a nosological problem. Proc Scand Migraine Society Arhus. 1978;31:
  133. Manjit M, et al. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Curr Pain Headache Rep. 2003;7:308–318
  134. Matharu M, Cohen A, Boes C, Goadsby P. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing: a review. Curr Pain Headache Rep. 2003;7:308–315
  135. Goadsby P, Lipton R. A review of paroxysmal hemicrania, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. 1997;120:193–209
  136. Blatter T, et al. Symptomatic SUNCT in an eleven-year-old girl. Neurology. 2003;60:2012–2013
  137. Kuhn W, Kuhn S, Gilberstadt H. Occipital neuralgias: clinical recognition of a complicated headache. J Orofac Pain. 1997;11:158–165
  138. Dugan M, Locke S, Gallagher R. Occipital neuralgia in adolescents and young adults. N Engl J Med. 1962;267:1166–1172
  139. Dalessio DJ. Diagnosis and treatment of cranial neuralgias. Med Clin North Am. 1991;75:605–615
  140. Kondev L, Minster A. Headache and facial pain in children and adolescents. Otolaryngol Clin North Am. 2003;36:1153–1170
  141. Marshall P, Rosman NP. Symptomatic trigeminal neuralgia in a 5-ear-old child. Pediatrics. 1977;60:331–333
  142. Lopes PG, Castro E, Lopes LH. Trigeminal neuralgia in children: two case reports. Pediatr Neurol. 2002;26:309–310
  143. Inanex V, Moreno M. Trigeminal neuralgia in children as the only manifestation of Chiari I malformation. Rev Neurol. 1999;28:485–487
  144. Roski RA, Horwitz S, Spetzler R. Atypical trigeminal neuralgia in a 6-ear-old boy. J Neurosurg. 1982;56:424–425
  145. Elias J, Kuniyoshi R, Carloni W, et al. Glossopharyngeal neuralgia associated with cardiac syncope. Ar Qbras Cardiol. 2002;78:510–519
  146. Childs A, Meaney J, Ferrie C, et al. Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports. Arch Dis Child. 2000;82:311–315
  147. Ekbom K, Westerberg C. Carbamazepine in glossopharyngeal neuralgia. Arch Neurol. 1966;14:595–596
  148. Wu Y, Chin C, Chan K, et al. Pediatric Chairi I malformations (Do clinical and radiologic features correlate?). Neurology. 1999;53:1271–1276
  149. Yglesias A, Narbona J, Vanaclocha V, et al. Chiari type I malformation, glossopharyngeal neuralgia and central sleep apnoea in a child. Dev Med Child Neurol. 1996;38:1126–1130
  150. Kandt RS, Daniel F. Glossopharyngeal neuralgia in a child (A diagnostic and therapeutic dilemma). Arch Neurol. 1986;43:301–302
  151. Lewis D, Frank LM, Toor S. Familial neck tongue syndrome. Headache. 2003;43:132–134
  152. Lewis DW, Qureshi FA. Acute headache in the Pediatric Emergency Department. Headache. 2000;40:200–203
  153. Burton LJ, Quinn B, Pratt-Cheney JL, et al. Headache etiology in a pediatric emergency room. Pediatr Emerg Care. 1997;13:1–4
  154. Callaghan M. Chronic posttraumatic headache in children and adolescents. Dev Med Child Neurol. 2001;43:819–822
  155. Quality Standards Subcommittee, American Academy of Neurology. Practice parameter (The management of concussions in sports). Neurology. 1997;48:581–585
  156. American College of Sports Medicine. Guidelines for the Management of Concussion in Sports. Rev. ed.. Denver, CO: Denver, Colorado Medical Society; 1991;

PII: S1538-5442(07)00018-1

doi: 10.1016/j.cppeds.2007.03.003

Current Problems in Pediatric and Adolescent Health Care
Volume 37, Issue 6 , Pages 207-246 , July 2007

Article Tools

* Image Usage & Resolution